Search Results 621-630 of 7687 for Subacute
A Study to Assess the Effectiveness and Safety of UGN-102 as a Primary Chemoablation Agent in Patients with Low Grade Non-Muscle-Invasive Bladder Cancer (LG ...
About this study. This is a multicenter, open-label, Phase 1, dose escalation trial to evaluate the safety, tolerability, and recommended Phase 2 dose ...
Mayo Clinic researchers are working to improve diagnosis and treatment of subarachnoid hemorrhages. Specific efforts include improved imaging of bleeding and ...
This is a single arm, open-label, multi-center, phase 1/2 study, to determine the safety and efficacy of KTE-X19, an autologous anti-CD19 chimeric antigen ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
About this study. The purpose of this study is to determine the efficacy and safety of investigational medical products (MEDI4736 monotherapy, tremelimumab ...
Ablation therapy is a procedure used to destroy abnormal tissue. Learn about the many different conditions treated with this minimally invasive treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.